Table 2. Occurrence of anti-hepatitis E virus antibody classes (IgA, IgM and IgG) and first detection and duration of IgM and IgG seropositivity in two serological assays, blood donors, Germany, 2011 (n = 10).
IgA | IgM | IgG | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mikrogen | Wantai | Mikrogen | Wantai | Mikrogen | Wantai | Mikrogen | Mikrogen | Wantai | Mikrogen | Wantai | Mikrogen | |||||
Donor | Mean time between samples in days (range) |
First positive detection on day xa |
Durationb and detection interval in days (range) |
Maximum concentration on day xa |
First positive detection on day xa |
First positive detection on day xa |
Durationb and detection interval in days (range) |
Durationb and detection interval in days (range) |
Maximum concentration on day xa |
Maximum concentration on day xa |
Maximum concentration (U/mL) | First positive detection on day xa |
First positive detection on day xa |
Maximum concentration on day xa |
Maximum concentration on day xa |
Maximum concentration (U/mL) |
D1 | 6 (3–14) |
8 | 5 (8) |
8 | 8 | 8 | > 55 (8 – >61) |
> 55 (8– >61) |
16 | 16 | 83.61 | 13 | 8 | 44 | 44 | 76.66 |
D2 | 17 (7–44) |
35 | 102 (35 – >132) |
68 | 35 | 35 | > 54 (35 – >84) |
> 54 (35 – >84) |
42 | 42 | 65.55 | 35 | 35 | 132 | 132 | 143.9 |
D3 | 17 (7–44) |
8 | 13 (8) |
8 | 0 | 0 | > 168 (0 – >168) |
> 52 (0 – >52) |
8 | 8 | 88.82 | 8 | 0 | 23 | 30 | 76.26 |
D4 | 11 (3–27) |
42 | 159 (42 – >194) |
48 | 42 | 42 | 159 (42 – >194) |
80 (42–111) |
48 | 48 | 93.62 | 42 | 42 | 111 | 130 | 149.39 |
D5 | 4 (3–11) |
0 | 47 (0 – >47) |
11 | 0 | 0 | > 47 (0 – >47) |
> 47 (0 – >47) |
0 | 0 | 96.95 | 0 | 0 | 47 | 47 | 96.61 |
D6 | 7 (6–8) |
28 | 130 (28– >154) |
28 | 28 | 28 | 130 (28 – >154) |
130 (28 – >154) |
28 | 28 | 123.91 | 28 | 28 | > 119 | > 119 | 167.64 |
D7 | 8 (3–46) |
40 | 6 (40) |
40 | 40 | 40 | 10 (40–46) |
34 (40 – >49) |
40 | 40 | 38.07 | 49 | 40 | 158 | 158 | 63.96 |
D8 | 7 (3–21) |
ND | ND | ND | 32 | 28 | 7 (1) |
23 (28–46) |
32 | 32 | 26.23 | 39 | 39 | 52 | 52 | 47.74 |
D9 | 11 (3–21) |
ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | 49 | 49 | 132 | > 137 | 56.05 |
D10 | 19 (4–38) |
ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | 59 | 59 | 59 | 59 | 65.03 |
Range | NC | 8–42 | 5–159 | 8–68 | 8–42 | 8–42 | 7–159 | 23–130 | 16–48 | 16–48 | 26.23–123.9 | 13–59 | 8–42 | 44–158 | 30–158 | 47.74–167.64 |
Meanc | NC | 31 | 80 | 38 | 31 | 30 | 69 | 63 | 34 | 34 | 71.83 | 34 | 32 | 103 | 89 | 108.20 |
Medianc | NC | 35 | 102 | 40 | 34 | 32 | 55 | 55 | 36 | 36 | 74.58 | 37 | 37 | 115 | 86 | 110.30 |
NC: not calculated; ND: no detection of antibodies.
a Day x post detection of HEV RNA by PCR screening.
b Duration: starting at half of the interval between the last negative and first positive sample and ending at half of the interval between last positive and first negative sample.
c IgA: donors D3, D5, D8, D9 and D10 were excluded from the calculation of mean and median values. IgM/IgG: donors D3, D5, D9 and D10 were excluded from the calculation of mean and median values. Donors were excluded either because no antibodies were detected (IgA: D8, IgM/IgG: D9 and D10) or because all samples were taken ≥ 30 days from each other (D3 and D5).